European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Portugal — market report, July 2025

Oncology drug tenders in Portugal in July 2025: 717 tenders published (+518% month on month, +401% year on year), estimated at €13,753,577 in total, and 736 contracts awarded (+498% month on month, +675% year on year), worth €2,603,604 (awarded value). Buyers with the most tenders: Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (85), Unidade Local de Saúde de Santa Maria, E. P. E. (83) and Unidade Local de Saúde do Alto Minho, EPE (ULSAM) (57); most contracts won: Generis – Farmaceutica, S.A. (44), Teva Pharma - Produtos Farmaceuticos,lda (33) and MYLAN, Lda. (28). On average 14.5 bids per contract; 3% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
717
Contracts awarded
736
Contract value awarded
€2,603,604
Bids per contract
14.5
Tenders published per month
05001K1.5KJul 24: 143Jul 24: 143Jul 24Aug 24: 62Aug 24: 62Aug 24Sep 24: 294Sep 24: 294Sep 24Oct 24: 241Oct 24: 241Oct 24Nov 24: 230Nov 24: 230Nov 24Dec 24: 967Dec 24: 967Dec 24Jan 25: 1,160Jan 25: 1,160Jan 25Feb 25: 931Feb 25: 931Feb 25Mar 25: 1,431Mar 25: 1,431Mar 25Apr 25: 1,156Apr 25: 1,156Apr 25May 25: 271May 25: 271May 25Jun 25: 116Jun 25: 116Jun 25Jul 25: 717Jul 25: 717717Jul 25
Contracts awarded per month
05001K1.5KJul 24: 95Jul 24: 95Jul 24Aug 24: 78Aug 24: 78Aug 24Sep 24: 253Sep 24: 253Sep 24Oct 24: 199Oct 24: 199Oct 24Nov 24: 386Nov 24: 386Nov 24Dec 24: 1,212Dec 24: 1,212Dec 24Jan 25: 1,017Jan 25: 1,017Jan 25Feb 25: 1,143Feb 25: 1,143Feb 25Mar 25: 1,418Mar 25: 1,418Mar 25Apr 25: 971Apr 25: 971Apr 25May 25: 117May 25: 117May 25Jun 25: 123Jun 25: 123Jun 25Jul 25: 736Jul 25: 736736Jul 25

The highlighted bar is July 2025. Hover a bar for its figure; the table below has every value.

FigureJuly 2025June 2025ChangeJuly 2024Change
Tenders published717116+518%143+401%
Estimated value€13,753,577€17,782,872-23%€14,909,023-8%
Buyers2520+25%13+92%
Contracts awarded736123+498%95+675%
Contract value (awarded)€2,603,604€997,634+161%€758,434+243%
Winners5444+23%31+74%
Bids per contract14.58.5—12.4—
Single-bid contracts3%15%—26%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Grande Lisboa 51

Procedures

  • not stated 665
  • Restricted procedure 50
  • Open procedure 2

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Portugal in July 2025?
717 (by 25 buyers); for comparison, June 2025: 116, July 2024: 143.
Who won the most oncology drug tenders in Portugal in July 2025?
By number of contracts: Generis – Farmaceutica, S.A. (44), Teva Pharma - Produtos Farmaceuticos,lda (33), MYLAN, Lda. (28), Fresenius Kabi Pharma Portugal (27) and Zentiva Portugal, Lda (26); 54 companies won contracts in all.
Which buyers published the most oncology drug tenders in July 2025?
Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (85), Unidade Local de Saúde de Santa Maria, E. P. E. (83), Unidade Local de Saúde do Alto Minho, EPE (ULSAM) (57), Unidade Local de Saúde do Algarve, E.P.E (55) and Unidade Local de Saúde da Lezíria, E. P. E. (40).
How competitive were oncology drug tenders in Portugal in July 2025?
On average 14.5 bids per contract (396 contracts with a known number of bids); 3% of contracts had a single bid.
What were the contracts worth in July 2025?
€2,603,604 (awarded value, 736 contracts); median about €290,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.